| 1 |
31969002 | Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection. | 2021 Jan 20 |
1 |
| 2 |
33306925 | A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease. | 2021 Jan |
1 |
| 3 |
33756027 | Evaluation of dysfunctional high-density lipoprotein levels with myeloperoxidase/paraoxonase-1 ratio in rheumatoid arthritis. | 2021 Jul |
2 |
| 4 |
33844899 | Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease. | 2021 Nov 24 |
1 |
| 5 |
34351918 | PON1 Q192R is associated with high platelet reactivity with clopidogrel in patients undergoing elective neurointervention: A prospective single-center cohort study. | 2021 |
1 |
| 6 |
34944413 | CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction. | 2021 Nov 25 |
1 |
| 7 |
31400246 | Paraoxonase 1 and atherosclerosis-related diseases. | 2020 Mar |
1 |
| 8 |
33072455 | Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2020 Sep 14 |
1 |
| 9 |
33135418 | A Membrane-free Liver-Gut-on-Chip Platform for the Assessment on Dysregulated Mechanisms of Cholesterol and Bile Acid Metabolism Induced by PM2.5. | 2020 Nov 25 |
1 |
| 10 |
30244352 | Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients. | 2019 |
1 |
| 11 |
30455362 | Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. | 2019 Jan |
1 |
| 12 |
31029939 | Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage. | 2019 Jun |
1 |
| 13 |
31038597 | Paraoxonase 1 serum activity in women: the effects of menopause, the C(-107)T polymorphism and food intake. | 2019 May-Jun |
1 |
| 14 |
31771252 | The Effects of Anthocyanins and Their Microbial Metabolites on the Expression and Enzyme Activities of Paraoxonase 1, an Important Marker of HDL Function. | 2019 Nov 24 |
2 |
| 15 |
29171874 | Serum paraoxonase-1 activity is inversely related to free thyroxine in euthyroid subjects: The PREVEND Cohort Study. | 2018 Jan |
3 |
| 16 |
29556488 | Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients. | 2018 Mar |
2 |
| 17 |
29732027 | Paraoxonase activity in metabolic syndrome in children and adolescents. | 2018 Spring |
1 |
| 18 |
30288380 | Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes. | 2018 Jun |
1 |
| 19 |
30376039 | Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study. | 2018 Dec 1 |
2 |
| 20 |
30544803 | Effect of Agraz (Vaccinium meridionale Swartz) on High-Density Lipoprotein Function and Inflammation in Women with Metabolic Syndrome. | 2018 Dec 8 |
1 |
| 21 |
30853125 | Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor. | 2018 Oct |
1 |
| 22 |
27757804 | Erratum to: Synthesis of Cholesterol-Conjugated Magnetic Nanoparticles for Purification of Human Paraoxonase 1. | 2017 Mar |
1 |
| 23 |
28032682 | Antiepileptic drugs: Impacts on human serum paraoxonase-1. | 2017 Jun |
1 |
| 24 |
28278274 | Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport. | 2017 |
3 |
| 25 |
28742600 | Cholesterol reduction and macrophage function: role of paraoxonases. | 2017 Oct |
5 |
| 26 |
26656640 | Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles. | 2016 Apr |
2 |
| 27 |
27262841 | High density lipoprotein subfractions and paraoxonase 1 in children. | 2016 |
1 |
| 28 |
27338244 | Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study. | 2016 Jun 23 |
1 |
| 29 |
27355189 | Serum Paraoxonase-1 Levels are Significantly Decreased in the Presence of Insulin Resistance. | 2016 Jul |
1 |
| 30 |
25487823 | Measurement of activity and concentration of paraoxonase 1 (PON-1) in seminal plasma and identification of PON-2 in the sperm of boar ejaculates. | 2015 Jan |
1 |
| 31 |
25887882 | Review: The role of paraoxonase in cardiovascular diseases. | 2015 Spring |
1 |
| 32 |
26103614 | How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. | 2015 Aug |
1 |
| 33 |
24285687 | Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. | 2014 Feb |
3 |
| 34 |
24700021 | Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. | 2014 Jun |
1 |
| 35 |
24704632 | Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease. | 2014 Jun |
2 |
| 36 |
24769273 | Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects. | 2014 Aug |
5 |
| 37 |
25038995 | Systemic inflammation, intestine, and paraoxonase-1. | 2014 |
1 |
| 38 |
25551104 | Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus. | 2014 |
2 |
| 39 |
23182497 | Positive correlation of paraoxonase 1 (PON1) activity with serum insulin level and HOMA-IR in dementia. A possible advantageous role of PON1 in dementia development. | 2013 Jan 15 |
1 |
| 40 |
23207490 | LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease. | 2013 |
1 |
| 41 |
23508039 | Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. | 2013 Aug |
1 |
| 42 |
23547806 | The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients. | 2013 Sep |
1 |
| 43 |
23768700 | Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. | 2013 Jul |
1 |
| 44 |
23958245 | The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome. | 2013 Sep |
1 |
| 45 |
23998046 | The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases. | 2013 Jul |
2 |
| 46 |
23998495 | Lipid mobilisation and oxidative stress as metabolic adaptation processes in dairy heifers during transition period. | 2013 Oct |
1 |
| 47 |
24124425 | Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis. | 2013 Apr |
1 |
| 48 |
24167353 | Reduced paraoxonase 1 activity as a marker for severe coronary artery disease. | 2013 |
1 |
| 49 |
24211756 | Metabolic syndrome in children with chronic kidney disease: PON1 and treatment modality. | 2013 Nov |
2 |
| 50 |
24267244 | Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease. | 2013 Dec |
2 |